Abstract
Background Novel coronavirus (SARS-CoV-2) has extended its range of transmission in all parts of the world, with substantial variation in rates of transmission and severity of associated disease. Many countries have implemented social distancing as a measure to control further spread.
Methods We evaluate whether and under which conditions containment or slowing down COVID-19 epidemics are possible by isolation and contact tracing in settings with various levels of social distancing. We use a stochastic transmission model in which every person generates novel infections according to a probability distribution that is affected by the incubation period distribution (time from infection to symptoms), distribution of the latent period (time from infection to onset of infectiousness), and overall transmissibility. The model distinguishes between close contacts (e.g., within a household) and other contacts in the population. Social distancing affects the number of contacts outside but not within the household.
Findings The proportion of asymptomatic or unascertained cases has a strong impact on the controllability of the disease. If the proportion of asymptomatic infections is larger than 30%, contact tracing and isolation cannot achieve containment for an R0 of 2.5. Achieving containment by social distancing requires a reduction of numbers of non-household contacts by around 90%. Depending on the realized level of contact reduction, tracing and isolation of only household contacts, or of household and non-household contacts are necessary to reduce the effective reproduction number to below 1. A combination of social distancing with isolation and contact tracing leads to synergistic effects that increase the prospect of containment.
Interpretation Isolation and contact tracing can be an effective means to slow down epidemics, but only if the majority of cases are ascertained. In a situation with social distancing, contact tracing can act synergistically and tip the scale towards containment, and can therefore be a tool for controlling COVID-19 epidemics as part of an exit strategy from current lockdown measures.
Funding This research was partly funded by ZonMw project number 91216062.
Author summary As of 2 April 2020, the novel coronavirus (SARS-CoV-2) has spread to more than 170 countries and has caused over 850,000 confirmed cases of COVID-19. In the absence of effective medicines and vaccines, the preventive measures are limited to social distancing, isolation of confirmed and suspected cases and identification of their contacts. Using a transmission model, we evaluated the impact of social distancing, isolation and contact tracing on slowing down or even containing COVID-19 epidemics. We investigated how various combinations of social distancing, isolation, and contact tracing reduce the effective reproduction number, and what is needed to achieve the critical threshold of a reproduction number below 1. We estimated the impact of combinations of measures on epidemic growth rate and doubling time for the number of infections. We find that under realistic assumptions on the level of social distancing, additional isolation and contact tracing are needed for stopping the epidemic. Whether quarantining only household contacts is sufficient, depends on levels of social distancing and timeliness of tracing and isolation. Our analyses, based on best understanding of the epidemiology of COVID-19, highlight that even if social distancing is in place, isolation and contact tracing at least of household contacts are needed to stop the epidemic, and these additional measures help to delay and lower the epidemic peak. Therefore, isolation and contact tracing will be important tools for enabling exiting of currently implemented social distancing measures.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was partly funded by ZonMw project number 91216062.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
We only used data from published literature.
